Il y a eu 50 transactions d'initiés récentes enregistrées pour Structure Therapeutics Inc. (GPCR), dont 28 achats et 22 ventes. Le total des achats d'initiés s'élève à $22.67M et le total des ventes d'initiés à $3.19M.
Les initiés notables ayant une activité récente comprennent Stevens Raymond C, Hall Ashley, Yoon Jun. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — GPCR
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-19 |
Stevens Raymond C |
Chief Executive Officer |
Attribution de RSU |
322,230 |
$16.82 |
$5.42M |
322,230 |
| 2026-03-19 |
Hall Ashley |
Chief Development Officer |
Attribution de RSU |
59,073 |
$16.82 |
$993.61K |
59,073 |
| 2026-03-19 |
Yoon Jun |
Chief Financial Officer |
Attribution de RSU |
128,892 |
$16.82 |
$2.17M |
128,892 |
| 2026-03-19 |
Lin Xichen |
Chief Scientific Officer |
Attribution de RSU |
53,703 |
$16.82 |
$903.28K |
53,703 |
| 2026-03-19 |
Ma Yingli |
Chief Technology Officer |
Attribution de RSU |
40,278 |
$16.82 |
$677.48K |
40,278 |
| 2026-03-19 |
Coll Crespo Blas |
Chief Medical Officer |
Attribution de RSU |
93,984 |
$16.82 |
$1.58M |
93,984 |
| 2026-03-03 |
Stevens Raymond C |
Chief Executive Officer |
Retenue Fiscale RSU |
53,454 |
$20.99 |
$1.12M |
1,141,376 |
| 2026-03-03 |
Hall Ashley |
Chief Development Officer |
Retenue Fiscale RSU |
4,836 |
$20.99 |
$101.51K |
107,481 |
| 2026-03-03 |
Yoon Jun |
Chief Financial Officer |
Retenue Fiscale RSU |
22,305 |
$20.99 |
$468.18K |
1,297,571 |
| 2026-03-03 |
Lin Xichen |
Chief Scientific Officer |
Retenue Fiscale RSU |
18,735 |
$20.99 |
$393.25K |
185,592 |
| 2026-03-03 |
Ma Yingli |
Chief Technology Officer |
Retenue Fiscale RSU |
11,313 |
$20.99 |
$237.46K |
107,391 |
| 2026-03-03 |
Coll Crespo Blas |
Chief Medical Officer |
Retenue Fiscale RSU |
11,826 |
$20.99 |
$248.23K |
204,981 |
| 2026-01-15 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
20 |
- |
- |
4,103 |
| 2025-12-08 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
15,535 |
- |
- |
- |
| 2025-11-20 |
Stevens Raymond C |
Chief Executive Officer |
Attribution de RSU |
824 |
- |
- |
1,824 |
| 2025-11-20 |
Hall Ashley |
Chief Development Officer |
Attribution de RSU |
237 |
- |
- |
462 |
| 2025-09-18 |
Hall Ashley |
Chief Development Officer |
Retenue Fiscale RSU |
6,021 |
$7.74 |
$46.62K |
112,317 |
| 2025-09-18 |
Coll Crespo Blas |
Chief Medical Officer |
Retenue Fiscale RSU |
8,106 |
$7.74 |
$62.77K |
216,807 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
26,310 |
- |
- |
1,515,558 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
Retenue Fiscale RSU |
12,846 |
$6.84 |
$87.82K |
204,327 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
Retenue Fiscale RSU |
4,470 |
$6.84 |
$30.56K |
118,704 |
| 2025-07-01 |
Stevens Raymond C |
Chief Executive Officer |
Retenue Fiscale RSU |
16,050 |
$6.84 |
$109.73K |
1,194,830 |
| 2025-07-01 |
Yoon Jun |
Chief Financial Officer |
Retenue Fiscale RSU |
7,089 |
$6.84 |
$48.46K |
1,319,876 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
Attribution de RSU |
57,078 |
- |
- |
217,173 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
Attribution de RSU |
24,459 |
- |
- |
123,174 |
| 2025-07-01 |
Coll Crespo Blas |
Chief Medical Officer |
Retenue Fiscale RSU |
1,434 |
$6.84 |
$9.8K |
224,913 |
| 2025-06-23 |
Love Ted W |
Director |
Attribution de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Dobmeier Eric |
Director |
Attribution de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Welch Daniel G |
Director |
Attribution de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Tetlow Sharon |
Director |
Attribution de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Russell Angus C. |
Director |
Attribution de RSU |
42,833 |
$7.37 |
$315.68K |
42,833 |
| 2025-06-23 |
Waldstreicher Joanne |
Director |
Attribution de RSU |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-05-21 |
Stevens Raymond C |
Chief Executive Officer |
Attribution de RSU |
1,000 |
- |
- |
1,000 |
| 2025-05-21 |
Yoon Jun |
Chief Financial Officer |
Attribution de RSU |
831 |
- |
- |
2,946 |
| 2025-05-21 |
Coll Crespo Blas |
Chief Medical Officer |
Attribution de RSU |
429 |
- |
- |
1,157 |
| 2025-05-20 |
Hall Ashley |
Chief Development Officer |
Attribution de RSU |
225 |
- |
- |
225 |
| 2025-03-15 |
Stevens Raymond C |
Chief Executive Officer |
Attribution de RSU |
826,890 |
$7.02 |
$5.8M |
826,890 |
| 2025-03-15 |
Hall Ashley |
Chief Development Officer |
Attribution de RSU |
51,048 |
- |
- |
118,338 |
| 2025-03-15 |
Yoon Jun |
Chief Financial Officer |
Attribution de RSU |
413,445 |
$7.02 |
$2.9M |
413,445 |
| 2025-03-15 |
Lin Xichen |
Chief Scientific Officer |
Attribution de RSU |
80,829 |
- |
- |
166,536 |
| 2025-03-15 |
Ma Yingli |
Chief Technology Officer |
Attribution de RSU |
63,810 |
- |
- |
100,539 |
| 2025-03-15 |
Coll Crespo Blas |
Chief Medical Officer |
Attribution de RSU |
116,988 |
- |
- |
219,588 |
| 2025-03-01 |
Stevens Raymond C |
Chief Executive Officer |
Retenue Fiscale RSU |
12,495 |
$7.92 |
$98.92K |
1,121,183 |
| 2025-03-01 |
Yoon Jun |
Chief Financial Officer |
Retenue Fiscale RSU |
5,940 |
$7.92 |
$47.02K |
1,287,359 |
| 2025-03-01 |
Lin Xichen |
Chief Scientific Officer |
Retenue Fiscale RSU |
6,441 |
$7.92 |
$50.99K |
160,095 |
| 2025-03-01 |
Ma Yingli |
Chief Technology Officer |
Retenue Fiscale RSU |
1,824 |
$7.92 |
$14.44K |
98,715 |
| 2025-03-01 |
Coll Crespo Blas |
Chief Medical Officer |
Retenue Fiscale RSU |
1,233 |
$7.92 |
$9.76K |
218,355 |
| 2025-02-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
41 |
- |
- |
- |
| 2024-11-20 |
Yoon Jun |
Chief Financial Officer |
Attribution de RSU |
821 |
- |
- |
2,115 |
| 2024-11-20 |
Coll Crespo Blas |
Chief Medical Officer |
Attribution de RSU |
363 |
- |
- |
728 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi